tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Emily Bodnar, 144 are a BUY (85.71%), 24 are a HOLD (14.29%).
Analyst Emily Bodnar, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 26.03% that have a potential upside of 119.43% achieved within 79 days.
Emily Bodnar’s has documented 323 price targets and ratings displayed on 17 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AGEN, Agenus at 22-Jan-2025.
Analyst best performing recommendations are on RNAZ (TRANSCODE THERAPEUTICS).
The best stock recommendation documented was for RNAZ (TRANSCODE THERAPEUTICS) at 11/15/2024. The price target of $3 was fulfilled within 19 days with a profit of $2.66 (782.35%) receiving and performance score of 411.76.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$48
$0.45 (0.95%)
$48
1 years 5 months 23 days ago
(09-Aug-2023)
1/8 (12.5%)
$0.45 (0.95%)
85
Hold
$56
1 years 7 months 6 days ago
(26-Jun-2023)
0/1 (0%)
$27.35 (95.46%)
Hold
$48
$0.45 (0.95%)
$68
1 years 7 months 12 days ago
(20-Jun-2023)
1/3 (33.33%)
$1.56 (3.36%)
27
Hold
$48
$0.45 (0.95%)
$38
1 years 7 months 12 days ago
(20-Jun-2023)
1/2 (50%)
$1.56 (3.36%)
27
Hold
$48
$0.45 (0.95%)
$71
1 years 7 months 12 days ago
(20-Jun-2023)
0/2 (0%)
$1.56 (3.36%)
Which stock is Emily Bodnar is most bullish on?
Which stock is Emily Bodnar is most reserved on?
What Year was the first public recommendation made by Emily Bodnar?
